forodesine hydrochloride (BCX-1777)
BCX1777-T-04-201
Phase 2 small_molecule completed
Quick answer
forodesine hydrochloride (BCX-1777) for Leukemia, T-Cell is a Phase 2 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Leukemia, T-Cell
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed